Lawrence Cameron William 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Dec 16, 2010
Insider Transaction Report
Form 4
Lawrence Cameron William
Principal Financial Officer
Transactions
- Award
Stock Option (right to buy)
2010-12-14$15.97/sh+4,000$63,880→ 4,000 totalExercise: $15.97Exp: 2020-12-14→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]The stock options vest monthly over four years.